ADVIL CONGESTION RELIEF Drug Patent Profile
✉ Email this page to a colleague
When do Advil Congestion Relief patents expire, and what generic alternatives are available?
Advil Congestion Relief is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in ADVIL CONGESTION RELIEF is ibuprofen; phenylephrine hydrochloride. There are sixty-four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ibuprofen; phenylephrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Advil Congestion Relief
A generic version of ADVIL CONGESTION RELIEF was approved as ibuprofen; phenylephrine hydrochloride by PERRIGO R AND D on July 3rd, 2014.
US Patents and Regulatory Information for ADVIL CONGESTION RELIEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL CONGESTION RELIEF | ibuprofen; phenylephrine hydrochloride | TABLET;ORAL | 022565-001 | May 27, 2010 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
